Despite the wealth of pre-clinical data to support MGMT's role in determining the outcome of methylating agent treatment in melanoma, evidence for the protein's importance in the clinic is inconclusive (Middleton et al, 1998; Ma et al, 2002; Middleton and Margison, 2003). Here, MGMT is linked to melanoma.